SWA
TEVA icon

SOA Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

SOA Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$4.41K – 911
2024
Q4 		$4.41K Buy
+200
New +$3.64K ﹤0.01% 629
2024
Q1 		– Sell
-43
Closed -$449 – 925
2023
Q4 		$449 Buy
+43
New +$401 ﹤0.01% 806

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

SOA Wealth Advisors's TEVA Position: Q1 2025 in Review

SOA Wealth Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2025, closing a stake of 200 shares — an estimated $4.41K sold.

SOA Wealth Advisors first reported a position in TEVA in Q4 2023 and held it in 2 quarters. The position peaked at $4.41K in Q4 2024. 563 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • SOA Wealth Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2025 after selling out during the quarter.
  • SOA Wealth Advisors sold 200 Teva Pharmaceutical Industries Limited shares in Q1 2025, an estimated $4.41K.
  • SOA Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2023 and held it in 2 quarters.
  • SOA Wealth Advisors's Teva Pharmaceutical Industries Limited position peaked at $4.41K in Q4 2024.
  • 563 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2025.

Based on SOA Wealth Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.